Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$89.85

11.76 (15.06%)

13:55
05/05/18
05/05
13:55
05/05/18
13:55

Sarepta winning over investors, Barron's says

Sarepta Therapeutics has been winning over investors with rising sales of its drug to treat Duchenne muscular dystrophy and a promising pipeline of drugs targeted at the fatal muscle-wasting disease, Andrew Bary writes in this week's edition of Barron's. Part of the optimism surrounding Sarepta is that it can bring to market two drugs similar to Exondys 51, which treats about 13% of DMD patients, he notes, adding that these drugs - casimersen and golodirsen - target mutations at other points on the dystrophin gene and could treat another 16% of DMD patients. Reference Link

SRPT Sarepta
$89.85

11.76 (15.06%)

05/04/18
NOMU
05/04/18
NO CHANGE
Target $131
NOMU
Buy
Sarepta price target raised to $131 form $96 at Nomura Instinet
Nomura Instinet analyst Christopher Marai raised his price target for Sarepta Therapeutics to $131 following the company's Q1 results. Management indicated that the quarter was negatively impacted by a switch from temporary to permanent J codes and patient insurance changes, Marai tells investors in a research note. The analyst keeps a Buy rating on the shares.
05/04/18
JMPS
05/04/18
NO CHANGE
Target $90
JMPS
Outperform
Sarepta price target lowered to $90 on likely EU rejection at JMP Securities
JMP Securities analyst Liisa Bayko said Sarepta's "impressive" Exondys 51 launch continued in Q1, though "it was not all sunshine for the exon 51 skipper" as it was also reported that the EMA's CHMP had a negative trend vote on the drug last week. The CHMP did not conclude that Exondys 51 is ineffective, which is a good sign, and Sarepta will file for a re-examination, said Bayko, though she thinks an approval is less likely and thus lowered her probability of success for Exondys 51 in the EU to 40% from 80% and pushed out expectations for a potential launch to 2021. Given the EU news, Bayko lowered her price target on Sarepta to $90 from $95, but she maintains her Outperform rating on the shares.
05/04/18
RBCM
05/04/18
NO CHANGE
Target $98
RBCM
Outperform
Sarepta price target raised to $98 from $91 at RBC Capital
RBC Capital analyst Brian Abrahams raised his price target on Sarepta to $98 and kept his Outperform rating. The analyst pointes to "solid" Q1 Exondys 51 sales serving to affirm his confidence in FY18 revenue outlook. Abrahams is also positive on Sarepta ahead of its initial microdystrophin gene therapy readout in June.
05/04/18
LEER
05/04/18
NO CHANGE
Target $88
LEER
Outperform
Sarepta base business and pipeline intact, says Leerink
Leerink analyst Joseph Schwartz said Sarepta's "hot streak hit a mostly expected blip" with Exondys51 sales coming in below expectation and EMA news that slows progress in Europe. While he is delaying his EU launch assumptions for eteplirsen, golodirsen, and casimersen due to the latest CHMP development, Schwartz sees the base business and pipeline progress being intact and he maintains an Outperform rating on Sarepta shares, though he lowered his price target to $88 from $92.

TODAY'S FREE FLY STORIES

TDOC

Teladoc

$78.10

2.675 (3.55%)

09:27
09/24/18
09/24
09:27
09/24/18
09:27
Recommendations
Teladoc analyst commentary  »

Teladoc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

PG

Procter & Gamble

$85.75

0.35 (0.41%)

, AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

09:26
09/24/18
09/24
09:26
09/24/18
09:26
Hot Stocks
Old Spice announces Beard Care Collection, available exclusively on Amazon.com »

Old Spice (PG) gets down…

PG

Procter & Gamble

$85.75

0.35 (0.41%)

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 19

    Oct

  • 03

    Mar

09:25
09/24/18
09/24
09:25
09/24/18
09:25
Conference/Events
Morgan Stanley household products analyst holds analyst/industry conference call »

Household Products,…

ANDV

Andeavor

$154.80

2.19 (1.44%)

, MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

09:25
09/24/18
09/24
09:25
09/24/18
09:25
Conference/Events
Marathon Petroleum to host special shareholder meeting »

Special Shareholder…

ANDV

Andeavor

$154.80

2.19 (1.44%)

MPC

Marathon Petroleum

$83.37

1.44 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

BFST

Business First Bancshares

$26.96

-0.41 (-1.50%)

09:24
09/24/18
09/24
09:24
09/24/18
09:24
Initiation
Business First Bancshares initiated  »

Business First Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

UTHR

United Therapeutics

$122.86

-1.42 (-1.14%)

09:23
09/24/18
09/24
09:23
09/24/18
09:23
Conference/Events
United Therapeutics to hold a meeting »

Science Day 2018 will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ZAGG

Zagg

$15.65

-0.15 (-0.95%)

09:21
09/24/18
09/24
09:21
09/24/18
09:21
Recommendations
Zagg analyst commentary  »

Zagg to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$162.90

-3.16 (-1.90%)

09:21
09/24/18
09/24
09:21
09/24/18
09:21
Periodicals
Facebook appoints Ajit Mohan as India managing director, The Times of India says »

Facebook has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

ABMD

Abiomed

$384.69

2.74 (0.72%)

09:20
09/24/18
09/24
09:20
09/24/18
09:20
Conference/Events
Abiomed to hold an investor breakfast meeting »

Annual Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 27

    Nov

BECN

Beacon Roofing

$39.38

-0.53 (-1.33%)

, OC

Owens Corning

$58.26

-0.34 (-0.58%)

09:18
09/24/18
09/24
09:18
09/24/18
09:18
Recommendations
Beacon Roofing, Owens Corning, Carlisle analyst commentary  »

Roofing estimates lowered…

BECN

Beacon Roofing

$39.38

-0.53 (-1.33%)

OC

Owens Corning

$58.26

-0.34 (-0.58%)

CSL

Carlisle

$123.80

-0.345 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 29

    Sep

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/24/18
09/24
09:18
09/24/18
09:18
Options
Overnight activity included 134 trades in SPX and 8 trades in VIX »

134 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$38.40

-2.7 (-6.57%)

09:17
09/24/18
09/24
09:17
09/24/18
09:17
Recommendations
uniQure analyst commentary  »

uniQure price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

FTV

Fortive

$86.97

-0.45 (-0.51%)

, AIMC

Altra Industrial Motion

$43.10

0.45 (1.06%)

09:17
09/24/18
09/24
09:17
09/24/18
09:17
Hot Stocks
Fortive sets final exchange ratio in split-off exchange offer »

Fortive Corporation (FTV)…

FTV

Fortive

$86.97

-0.45 (-0.51%)

AIMC

Altra Industrial Motion

$43.10

0.45 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$38.40

-2.7 (-6.57%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Hot Stocks
uniQure says third patient has been treated in AMT-061 study »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

NVDA

Nvidia

$263.44

-2.83 (-1.06%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Recommendations
Nvidia analyst commentary  »

Mixed reaction to Nvidia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 10

    Dec

TSLA

Tesla

$299.05

0.73 (0.24%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Recommendations
Tesla analyst commentary  »

Tesla Model 3 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 29

    Oct

DNB

Dun & Bradstreet

$143.01

-0.26 (-0.18%)

09:16
09/24/18
09/24
09:16
09/24/18
09:16
Hot Stocks
Dun & Bradstreet announce expiration of 'Go Shop' period »

Dun & Bradstreet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$119.85

-0.31 (-0.26%)

09:15
09/24/18
09/24
09:15
09/24/18
09:15
Conference/Events
Neurocrine has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CRM

Salesforce

$155.46

-0.07 (-0.05%)

09:14
09/24/18
09/24
09:14
09/24/18
09:14
Hot Stocks
Apple, Salesforce announce strategic partnership »

Apple and Salesforce…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CRM

Salesforce

$155.46

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

HAFC

Hanmi Financial

$25.65

-0.45 (-1.72%)

09:14
09/24/18
09/24
09:14
09/24/18
09:14
Conference/Events
Goldman Sachs to hold a conference »

9th Annual Regional &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

CMTL

Comtech

$33.32

0.5 (1.52%)

09:11
09/24/18
09/24
09:11
09/24/18
09:11
Hot Stocks
Comtech receives $9.1M contract to supply troposcatter equipment to Iraqi Navy »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

STM

STMicroelectronics

$18.83

-0.22 (-1.15%)

09:10
09/24/18
09/24
09:10
09/24/18
09:10
Hot Stocks
STMicroelectronics, Leti announce cooperation to develop GaN-on-Silicon tech »

STMicroelectronics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
09/24/18
09/24
09:10
09/24/18
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CMCSA

Comcast

$37.91

0.1 (0.26%)

, DIS

Disney

$110.72

-0.9 (-0.81%)

09:09
09/24/18
09/24
09:09
09/24/18
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Disney (DIS), up…

CMCSA

Comcast

$37.91

0.1 (0.26%)

DIS

Disney

$110.72

-0.9 (-0.81%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

AMRN

Amarin

$3.00

0.06 (2.04%)

EPZM

Epizyme

$10.30

-0.1 (-0.96%)

P

Pandora

$9.08

-0.31 (-3.30%)

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

GOLD

Randgold

$63.94

-0.64 (-0.99%)

ABX

Barrick Gold

$10.48

-0.135 (-1.27%)

XON

Intrexon

$14.50

-0.035 (-0.24%)

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

BILI

Bilibili

$12.47

-0.93 (-6.94%)

ANAB

AnaptysBio

$92.83

0.61 (0.66%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 02

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

IMPV

Imperva

$45.65

-0.6 (-1.30%)

, FIVN

Five9

$43.21

-1.32 (-2.96%)

09:07
09/24/18
09/24
09:07
09/24/18
09:07
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$45.65

-0.6 (-1.30%)

FIVN

Five9

$43.21

-1.32 (-2.96%)

CDAY

Ceridian

$42.07

-0.855 (-1.99%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 28

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.